What helps prolonged grief? A targeted therapy beats an antidepressant

Grief is not an illness, and most people move through even devastating loss without formal treatment. But for a minority the grief stays acute and disabling for months or years — a condition now recognised as prolonged or complicated grief — and here the evidence is unusually clear. A grief-specific psychotherapy outperforms both an antidepressant and a proven depression therapy, while the antidepressant on its own does not beat placebo for grief itself [s1][s2]. In other words, what helps most is a treatment built for grief, not a drug borrowed from depression care.

The trial that separated the pieces

The sharpest evidence is a 2016 randomised clinical trial in JAMA Psychiatry, the first placebo-controlled study to test drug and talking treatments for complicated grief in the same design [s1]. It enrolled 395 bereaved adults who met criteria for complicated grief at four US academic centres and randomised them four ways: citalopram alone (101 people), placebo alone (99), complicated grief treatment plus citalopram (99), and complicated grief treatment plus placebo (96), with independent assessors following them for 20 weeks [s1].

The results pulled the drug and the therapy apart. Complicated grief treatment plus placebo produced a response in 82.5% of people, against 54.8% on placebo alone — a relative risk of 1.51 (95% CI 1.16 to 1.95; P = .002), meaning about one extra person responded for every 3.6 treated [s1]. Adding citalopram to the therapy did nothing for grief response: 83.7% versus 82.5%, essentially identical [s1]. And citalopram alone never significantly outperformed placebo on grief, either at week 12 (45.9% versus 37.9%) or week 20 (69.3% versus 54.8%) [s1].

Where the drug earned its place

The antidepressant was not useless — it was aimed at the wrong target. When grief is tangled with depression, as it often is, citalopram helped: adding it to the therapy reduced depressive symptoms significantly more than the therapy alone (adjusted mean difference -2.06, 95% CI -4.02 to -0.11; P = .04) [s1]. And the therapy improved the drug's showing — people on citalopram did better when grief treatment was added (83.7% versus 69.3% for citalopram alone; RR 1.21, 95% CI 1.00 to 1.46) [s1]. The authors' conclusion was that complicated grief treatment is the treatment of choice, with an antidepressant reserved for optimising any depression that comes with it [s1].

Confirmed in older adults

An earlier trial from the same group tested the therapy against a strong rival rather than a placebo, and the pattern held [s2]. It randomised 151 people aged 50 or older (mean age 66.1) with complicated grief to either the grief-specific treatment or grief-focused interpersonal psychotherapy — a well-established therapy for depression [s2]. Response rates were 70.5% for complicated grief treatment versus 32.0% for interpersonal psychotherapy, a relative risk of 2.20 (95% CI 1.51 to 3.22; P < .001) and a number needed to treat of just 2.56 [s2]. Grief symptoms fell faster too, and the authors argued the results show why clinicians must distinguish complicated grief from ordinary depression rather than treating them the same way [s2]. That distinction is the practical heart of both trials: interpersonal psychotherapy is a genuinely effective depression treatment, yet it was outperformed roughly two to one when the target was grief rather than mood — which is exactly why reaching for a general depression treatment, drug or talk, tends to underperform here.

What it means

For someone whose grief has not eased and is still derailing daily life long after a loss, the takeaway is specific: seek a therapy designed for grief, not simply an antidepressant. The treatment studied here works on the two things that keep grief stuck — avoiding reminders of the loss and struggling to imagine a life alongside it — and in trials it roughly doubled response rates against serious comparators [s1][s2]. Medication has a supporting role when depression rides along, but it is not the lead treatment [s1].

None of this pathologises normal mourning, which needs time and support rather than a clinic. The signal to get help is grief that stays intense and impairing for many months. Anyone in that position — and especially anyone having thoughts of not wanting to be alive — should talk to a GP or mental health professional. This article describes evidence and is not medical advice.

Sources

• Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial — JAMA Psychiatry, 2016-07-01
• Treatment of complicated grief in elderly persons: a randomized clinical trial — JAMA Psychiatry, 2014-11-01